[Revised practice guideline 'Screening and diagnosis of breast cancer']

Autor: Hm, Zonderland, Mk, Tuut, Gj, Den Heeten, Cj, Asperen, Gh, Bock, Ej, Rutqers, Pieter Westenend, Gm, Smit, Benraadt J

Publikováno v: Europe PubMed Central

Revised practice guideline 'Screening and diagnosis of breast cancer' The evidence-based revision of the practice guideline 'Screening and diagnosis of breast cancer' was necessitated by new insights, for instance on the cost-effectiveness of screeni

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::dbf19953751541bf4989de55df1bd164
https://pubmed.ncbi.nlm.nih.gov/19024064

Cost-effectiveness of Breast Cancer Screening With Magnetic Resonance Imaging for Women at Familial Risk.

Autor: Geuzinge HA; Department of Public Health, Erasmus University Medical Center, Rotterdam, the Netherlands., Obdeijn IM; Department of Radiology and Nuclear Medicine, Erasmus University Medical Center, Rotterdam, the Netherlands., Rutgers EJT; Department of Surgery, the Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands., Saadatmand S; Department of Surgery, Erasmus University Medical Center, Rotterdam, the Netherlands., Mann RM; Department of Radiology and Nuclear Medicine, Radboud University Hospital, Nijmegen, the Netherlands.; Department of Radiology and Nuclear Medicine, the Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands., Oosterwijk JC; Department of Surgery, Medical Centre Leeuwarden, Leeuwarden, the Netherlands.; Department of Genetics, Groningen University, University Medical Centre Groningen, Groningen, the Netherlands., Tollenaar RAEM; Department of Surgery, Leiden University Medical Centre, Leiden, the Netherlands., de Roy van Zuidewijn DBW; Department of Surgery, Medical Centre Leeuwarden, Leeuwarden, the Netherlands., Lobbes MBI; Department of Radiology and Nuclear Medicine, Maastricht University Medical Center, Maastricht, the Netherlands., van 't Riet M; Department of Surgery, Reinier de Graaf Gasthuis, Delft, the Netherlands., Hooning MJ; Department of Medical Oncology, Erasmus University Medical Center, Rotterdam, the Netherlands., Ausems MGEM; Department of Genetics, University Medical Centre Utrecht, Utrecht, the Netherlands., Loo CE; Department of Radiology and Nuclear Medicine, the Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands., Wesseling J; Department of Pathology, the Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands., Luiten EJT; Department of Surgery, Amphia Ziekenhuis, Breda, the Netherlands., Zonderland HM; Department of Radiology and Nuclear Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands., Verhoef C; Department of Surgery, Erasmus University Medical Center, Rotterdam, the Netherlands., Heijnsdijk EAM; Department of Public Health, Erasmus University Medical Center, Rotterdam, the Netherlands., Tilanus-Linthorst MMA; Department of Surgery, Erasmus University Medical Center, Rotterdam, the Netherlands., de Koning HJ; Department of Public Health, Erasmus University Medical Center, Rotterdam, the Netherlands.

Publikováno v: JAMA oncology [JAMA Oncol] 2020 Sep 01; Vol. 6 (9), pp. 1381-1389.

Transformation of the National Breast Cancer Guideline Into Data-Driven Clinical Decision Trees.

Autor: Hendriks MP; Northwest Clinics, Alkmaar, the Netherlands., Verbeek XAAM; Netherlands Comprehensive Cancer Organization, Utrecht, the Netherlands., van Vegchel T; Netherlands Comprehensive Cancer Organization, Utrecht, the Netherlands., van der Sangen MJC; Catharina Hospital, Eindhoven, the Netherlands., Strobbe LJA; Canisius Wilhelmina Hospital, Nijmegen, the Netherlands., Merkus JWS; Haga Teaching Hospital, The Hague, the Netherlands., Zonderland HM; University of Amsterdam, the Netherlands., Smorenburg CH; Netherlands Cancer Institute, Amsterdam, the Netherlands., Jager A; Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Siesling S; Netherlands Comprehensive Cancer Organization, Utrecht, the Netherlands.; University of Twente, Enschede, the Netherlands.

Publikováno v: JCO clinical cancer informatics [JCO Clin Cancer Inform] 2019 May; Vol. 3, pp. 1-14.

Minimal impact of adjuvant exemestane or tamoxifen treatment on mammographic breast density in postmenopausal breast cancer patients: a Dutch TEAM trial analysis.

Autor: van Nes JG; Department of Surgery, Leiden University Medical Centre , Leiden , The Netherlands., Beex LV, Seynaeve C, Putter H, Sramek A, Lardenoije S, Duijm-de Carpentier M, Van Rongen I, Nortier JW, Zonderland HM, van de Velde CJ

Publikováno v: Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2015 Mar; Vol. 54 (3), pp. 349-60. Date of Electronic Publication: 2014 Nov 10.

The Breast Imaging Reporting and Data System (BI-RADS) in the Dutch breast cancer screening programme: its role as an assessment and stratification tool.

Autor: Timmers JM; National Expert and Training Centre for Breast Cancer Screening, PO Box 6873, 6503 GJ Nijmegen, the Netherlands. j.timmers@lrcb.nl, van Doorne-Nagtegaal HJ, Zonderland HM, van Tinteren H, Visser O, Verbeek AL, den Heeten GJ, Broeders MJ

Publikováno v: European radiology [Eur Radiol] 2012 Aug; Vol. 22 (8), pp. 1717-23. Date of Electronic Publication: 2012 Mar 14.